...Sailish Honap; Isabelle Aimone-Gastin; Sylvain Salignac; Justine Flayac; Justine Paoli; Laurent Peyrin-Biroulet; Abderrahim Oussalah Introduction: Fecal calprotectin is a validated biomarker for assessing disease activity in patients with inflammatory bowel disease (IBD). Blood calprotectin...

...Robin Mona; Andreas Göldi; Tobias Schneider; Isabelle Panne; Andrea Egger; Jan Hendrik Niess; Petr Hrúz Introduction: Fatigue is an extraintestinal manifestation in patients with inflammatory bowel disease (IBD), such as Crohn’s disease (CD) and ulcerative colitis (UC), with limited information...

... accompanying images. We report the first case of asymptomatic WD diagnosed during the treatment for UC. Table 1 shows the list of previous case reports of co-existing WD and inflammatory bowel disease (IBD), identified through a literature search on PubMed and Embase (until July 2024). These reports have...

...Maya Nunotani; Miho Takahashi; Takuro Miyazaki Introduction: This study aimed to develop and validate a burden scale for colonoscopy-specific experiences among patients with inflammatory bowel disease (IBD) and to assess its reliability and validity. Methods: Building upon previous research...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Inflammatory bowel disease Ulcerative colitis Heart rate variability Wearable smart watch Autonomic nervous system Inflammatory bowel disease (IBD) is a chronic...

...Hikaru Mizuno; Yu Fujimoto; Yoshiko Furukawa; Mayu Katashima; Koji Yamamoto; Kayoko Sakagami; Maya Nunotani; Natsuko Seto Introduction: The number of patients with inflammatory bowel disease (IBD) in Japan has continued to increase, leading to diverse and complex patient backgrounds. Despite...

..., instructions or products referred to in the content or advertisements. 2024 Crohn’s disease Tacrolimus Postoperative complications Inflammatory bowel disease Calcineurin inhibitor Despite the growing number of immunosuppressive agents available to treat Crohn’s Disease (CD) patients, many...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Inflammatory bowel disease Observational study Ulcerative colitis...

...Eujin Lee; Hiroaki Tsuchiya; Hajime Iida; Katsumasa Nagano; Yoko Murata; Atsuo Maemoto Introduction: Patients with inflammatory bowel disease (IBD) are increasingly using online platforms to communicate with other patients and healthcare professionals seeking disease-related information and support...

...Michael Farber; Jeremy Polman; Nina Kohn; Vincent Chua; Arun Swaminath; Keith Sultan Introduction: A secondary loss of response (LOR) to infliximab (IFX) therapy for inflammatory bowel disease (IBD) is typically associated with low IFX trough levels, often with high levels of neutralizing...

...Julie Pillet; Julia Voirol-Perrin; Myriam Martel; Omar Kherad; Sophie Restellini Introduction: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are associated to poor maternal and foetal outcomes during pregnancy, requiring a strict monitoring...

...Kuninori Iwayama; Kazuya Hiura; Ko-Ichi Ohtaki Introduction: In pharmacotherapy for inflammatory bowel disease (IBD), good medication adherence is necessary to control the condition. However, some patients show poor adherence. Pharmacists need to provide appropriate medication guidance to improve...

...Toshifumi Morishita; Shunichi Yanai; Yosuke Toya; Takayuki Matsumoto Introduction: With the recent increase in number of drugs for treating inflammatory bowel disease (IBD), it has become important to select treatments acceptable to patients. Endoscopy and biomarkers from blood and stool samples...

...Helena Gensmyr-Singer; Pontus Karling Introduction: The clinical consequences for patients with inflammatory bowel disease (IBD) who stop treatment owing to side effects have not been fully investigated. Methods: This retrospective observational study aimed to compare patients who discontinued...

...Hikaru Mizuno; Yu Fujimoto; Yoshiko Furukawa; Mayu Katashima; Koji Yamamoto; Kayoko Sakagami; Maya Nunotani; Natsuko Seto Introduction: This study focuses on developing and validating an e-learning educational program for nurturing inflammatory bowel disease (IBD) nursing specialists. Methods...

...Hikaru Mizuno; Mayu Katashima; Kayoko Sakagami; Yu Fujimoto; Chiyo Murauchi; Natsuko Seto Introduction: Currently, no self-care measurement tool specific to inflammatory bowel disease (IBD) exists in Japan. The Instrument for Diabetes Self-care Agency (IDSCA) is a reliable and valid self-care...

...Masatomo Ogata; Masaki Kato; Takamasa Miyauchi; Marie Murata-Hasegawa; Yuko Sakurai; Kazunobu Shinoda; Hajime Yamazaki; Yugo Shibagaki; Masahiko Yazawa Introduction: Gastrointestinal complications are common after solid organ transplantation. New-onset inflammatory bowel disease (IBD) after...

...Mahmoud Mosli Introduction: Multiple therapies are currently available for inflammatory bowel disease (IBD); it is therefore crucial to understand patterns of drug change. This study aimed to examine the patterns of biological drug change and identify predictors of change in patients with IBD...

[email protected] 3 02 2023 15 12 2023 28 12 2023 Immunomodulator Inflammatory bowel disease Leukocyte Maintenance therapy Remission Ulcerative colitis The incidence of ulcerative colitis (UC), a chronic gut inflammatory disease, has been increasing worldwide [ 1...

..., instructions or products referred to in the content or advertisements. 2023 Ulcerative colitis Ultrasound Inflammatory bowel disease Prediction Fecal calprotectin Advances in ulcerative colitis (UC) treatment have enabled short-term symptomatic improvement and maintenance of long-term...